April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Role of Ca2+-permeable AMPA receptor in retinal ischemia models
Author Affiliations & Notes
  • Ai Ling Wang
    Ophthal & Visual Sci, Albert Einstein School of Medicine, Bronx, NY
  • Scott A Nawy
    Ophthalmology, Albert Einstein College of Medicine, Bronx, NY
  • Footnotes
    Commercial Relationships Ai Ling Wang, None; Scott Nawy, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1905. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ai Ling Wang, Scott A Nawy; Role of Ca2+-permeable AMPA receptor in retinal ischemia models. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1905.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Purpose: Recent work has found that expression of the Ca2+-permeable AMPA receptor (CP-AMPAR) is elevated following transient global forebrain ischemia, resulting in increased neuronal death. Retinal ischemia is also associated with neuronal death, particularly the death of retinal ganglion cells, and can lead to blindness. At present, there is no effective treatment against retinal ischemic damage. The purpose of the present study was two fold: 1) We tested the hypothesis that CP-AMPARs are upregulated following ischemic insult, and that Ca2+ influx through these channels contributes to RGC death in retinal ischemia. 2) We investigated the idea that global forebrain ischemia can also damage RGCs through the same mechanisms as retinal ischemia.

Methods: Two in vivo animal models were used. One was a transient, global cerebral ischemia (4-VO) model, and the other was a retinal ischemia/reperfusion model. In addition, the oxygen/glucose deprivation (OGD) model was established in cultured primary RGCs. To test for changes in AMPAR expression, we measured levels of GluA2, a subunit that, following Q/R editing by ADAR2, renders AMPARs impermeable to Ca2+. In separate experiments, siRNA was used to knockdown levels of ADAR2 in primary culture to directly test the hypothesis that increased expression of CP-AMPARs contributes to RGCs death.

Results: Using real-time RT-PCR, we found a 75% decrease in GluA2 expression in the retina in the 4-VO model, and a 65% decrease in GluA2 expression in response to increased IOP in the ischemia/reperfusion model at 1 week, suggesting that both forms of ischemia can induce changes in AMPAR composition. We also observed a decrease in GluA2 immunoreactivity in retinal neural cell cultures exposed to OGD. This decrease was confirmed by real-time RT-PCR and western blots. In a second series of experiments, we used Co2+ staining and electrophysiology to confirm that ADAR2 siRNA increased Ca2+ permeability through AMPARs. Importantly, the susceptibility of RGCs to AMPA induced excitotoxicity was dramatically increased in siRNA-treated RGCs compared with control or sham siRNA treated RGCs.

Conclusions: We investigated the function of increased CP-AMPARs levels on RGCs function and viability. Our work suggests that global ischemia can increase expression of CP-AMPARs in RGCs, and that Ca2+ influx into RGCs as a result of increased CP-AMPARs may play a role in the pathogenesis of retinal ischemia.

Keywords: 572 ischemia • 688 retina  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.